论文部分内容阅读
目的:观察胺碘酮治疗充血性心力衰竭伴室性心律失常的的临床疗效。方法:选择我院2012年3月~2014年6月收治的64例充血性心力衰竭伴室性心律失常患者,随机分为观察组和对照组,各32例。两组均给予利尿、强心、营养心肌等治疗,观察组在此基础上给予胺碘酮治疗。结果:观察组和对照组各32例,观察组心力衰竭总有效率为93.75%,对照组为71.88%;观察组心律失常有效率为93.75%,对照组为50.00%,均为观察组明显高于对照组(P<0.01)。结论:胺碘酮治疗充血性心力衰竭伴室性心律失常疗效确切,安全、有效,值得推广。
Objective: To observe the clinical efficacy of amiodarone in the treatment of congestive heart failure with ventricular arrhythmia. Methods: Sixty-four patients with congestive heart failure and ventricular arrhythmia admitted to our hospital from March 2012 to June 2014 were randomly divided into observation group and control group, with 32 cases in each group. Both groups were given diuretic, cardiac, nutritional myocardium and other treatment, the observation group on this basis to give amiodarone treatment. Results: The observation group and the control group, 32 cases in each group, the observation group, the total effective rate of heart failure was 93.75%, 71.88% in the control group; observation group, the arrhythmia efficiency was 93.75%, 50.00% in the control group were significantly higher in the observation group In the control group (P <0.01). Conclusion: Amiodarone is effective, safe and effective in the treatment of congestive heart failure with ventricular arrhythmia and is worth promoting.